BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15831425)

  • 1. Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX.
    Daldrup-Link HE; Rudelius M; Oostendorp RA; Jacobs VR; Simon GH; Gooding C; Rummeny EJ
    Acad Radiol; 2005 Apr; 12(4):502-10. PubMed ID: 15831425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment.
    Daldrup-Link HE; Rudelius M; Piontek G; Metz S; Bräuer R; Debus G; Corot C; Schlegel J; Link TM; Peschel C; Rummeny EJ; Oostendorp RA
    Radiology; 2005 Jan; 234(1):197-205. PubMed ID: 15618382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of hematopoietic progenitor cells with MR contrast agents.
    Daldrup-Link HE; Rudelius M; Oostendorp RA; Settles M; Piontek G; Metz S; Rosenbrock H; Keller U; Heinzmann U; Rummeny EJ; Schlegel J; Link TM
    Radiology; 2003 Sep; 228(3):760-7. PubMed ID: 12881578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood.
    Ju S; Teng G; Zhang Y; Ma M; Chen F; Ni Y
    Magn Reson Imaging; 2006 Jun; 24(5):611-7. PubMed ID: 16735183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labeling efficacy of superparamagnetic iron oxide nanoparticles to human neural stem cells: comparison of ferumoxides, monocrystalline iron oxide, cross-linked iron oxide (CLIO)-NH2 and tat-CLIO.
    Song M; Moon WK; Kim Y; Lim D; Song IC; Yoon BW
    Korean J Radiol; 2007; 8(5):365-71. PubMed ID: 17923778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.
    Daldrup-Link HE; Meier R; Rudelius M; Piontek G; Piert M; Metz S; Settles M; Uherek C; Wels W; Schlegel J; Rummeny EJ
    Eur Radiol; 2005 Jan; 15(1):4-13. PubMed ID: 15616814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro.
    Metz S; Bonaterra G; Rudelius M; Settles M; Rummeny EJ; Daldrup-Link HE
    Eur Radiol; 2004 Oct; 14(10):1851-8. PubMed ID: 15249981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive tracking of human haemopoietic CD34(+) stem cells in vivo in immunodeficient mice by using magnetic resonance imaging.
    Niemeyer M; Oostendorp RA; Kremer M; Hippauf S; Jacobs VR; Baurecht H; Ludwig G; Piontek G; Bekker-Ruz V; Timmer S; Rummeny EJ; Kiechle M; Beer AJ
    Eur Radiol; 2010 Sep; 20(9):2184-93. PubMed ID: 20393719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell (CD34+) uptake of superparamagnetic iron oxide is enhanced by but not dependent on a transfection agent.
    England TJ; Bath PM; Abaei M; Auer D; Jones DR
    Cytotherapy; 2013 Mar; 15(3):384-90. PubMed ID: 23579062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.
    Arbab AS; Bashaw LA; Miller BR; Jordan EK; Lewis BK; Kalish H; Frank JA
    Radiology; 2003 Dec; 229(3):838-46. PubMed ID: 14657318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3T.
    Ittrich H; Lange C; Tögel F; Zander AR; Dahnke H; Westenfelder C; Adam G; Nolte-Ernsting C
    J Magn Reson Imaging; 2007 Jun; 25(6):1179-91. PubMed ID: 17520738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison.
    Sun R; Dittrich J; Le-Huu M; Mueller MM; Bedke J; Kartenbeck J; Lehmann WD; Krueger R; Bock M; Huss R; Seliger C; Gröne HJ; Misselwitz B; Semmler W; Kiessling F
    Invest Radiol; 2005 Aug; 40(8):504-13. PubMed ID: 16024988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.
    Zhang B; Jiang B; Chen Y; Huang H; Xie Q; Kang M; Zhang H; Zhai C; Wu Y
    Contrast Media Mol Imaging; 2012; 7(1):35-44. PubMed ID: 22344878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells.
    Arbab AS; Yocum GT; Rad AM; Khakoo AY; Fellowes V; Read EJ; Frank JA
    NMR Biomed; 2005 Dec; 18(8):553-9. PubMed ID: 16229060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo MR imaging of magnetically labeled human embryonic stem cells.
    Tallheden T; Nannmark U; Lorentzon M; Rakotonirainy O; Soussi B; Waagstein F; Jeppsson A; Sjögren-Jansson E; Lindahl A; Omerovic E
    Life Sci; 2006 Aug; 79(10):999-1006. PubMed ID: 16828117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.
    Frank JA; Miller BR; Arbab AS; Zywicke HA; Jordan EK; Lewis BK; Bryant LH; Bulte JW
    Radiology; 2003 Aug; 228(2):480-7. PubMed ID: 12819345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the homing of human CD34+ cells in mouse bone marrow using clinical MR imaging.
    Akbari AA; Mozdarani H; Akhlaghpoor Sh; Pourfatollah AA; Soleimani M
    Pak J Biol Sci; 2007 Mar; 10(6):833-42. PubMed ID: 19069876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques.
    Arbab AS; Bashaw LA; Miller BR; Jordan EK; Bulte JW; Frank JA
    Transplantation; 2003 Oct; 76(7):1123-30. PubMed ID: 14557764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo MR imaging of magnetically labeled mesenchymal stem cells transplanted into rat liver through hepatic arterial injection.
    Cai J; Zhang X; Wang X; Li C; Liu G
    Contrast Media Mol Imaging; 2008; 3(2):61-6. PubMed ID: 18381616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver.
    Bos C; Delmas Y; Desmoulière A; Solanilla A; Hauger O; Grosset C; Dubus I; Ivanovic Z; Rosenbaum J; Charbord P; Combe C; Bulte JW; Moonen CT; Ripoche J; Grenier N
    Radiology; 2004 Dec; 233(3):781-9. PubMed ID: 15486216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.